Dr Jennifer Van Eyk

The new Advanced Clinical BioSystems Research Institute's motto, "from discovery to patient care," underlies the essence and foundation of our research. Our research focuses on i) understanding the molecular mechanisms underlying acute and chronic disease and the development of precision therapies and ii) in the development of clinically robust circulating biomarkers for personalization of medical care. The central philosophy of our laboratory is that compelling biological and clinical questions drive innovation through development, optimization and adaption of proteomic technologies, functional analysis, and large-scale mass spectrometry and data handling. Using robust automated technological proteomic pipelines that our group has developed we are able to precisely quantify proteins and their post-translational modifications in disease pathways and provide disease signatures and alterations in response to therapeutic intervention.